Home / Inspections / 1293422

FDA Inspection 1293422 — Seattle Reproductive Medicine, Inc., P.S.

Seattle Reproductive Medicine, Inc., P.S. — FEI 3009672546

The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on September 16, 2025 in Bellevue, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 16, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Bellevue, WA (United States)

Facility

Other inspections at this facility

  • 1171334 (NAI Thu Apr 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031414 (NAI Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 961640 (NAI Wed Feb 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865541 (NAI Mon Feb 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources